APO Research
Talk to an analyst

APO RESEARCH · REPORT

Codeine

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Selected research

Market Analysis & Forecast

Global Codeine Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchCodeine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Codeine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.

This report presents an overview of global market for Codeine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Codeine, also provides the sales of main regions and countries. Of the upcoming market potential for Codeine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Codeine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Codeine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Codeine sales, projected growth trends, production technology, application and end-user industry.

Codeine Segment by Company

Taiji

Mallinckrodt

TEVA

Johnson & Johnson

Medreich

Sanofi Aventis

Cipla

Hikma

Pharmaceutical Associates

Novartis

Apotex

Mylan

Aristo Pharma GmbH

Lannett Company

Laboratoire Riva

Codeine Segment by Ingredient

Single-ingredient Codeine

Multi-ingredient Medications

Codeine Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Codeine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Codeine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Codeine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Codeine Market Size Growth Rate by Ingredient (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-ingredient Codeine Major Manufacturers Table 3. Multi-ingredient Medications Major Manufacturers Table 4. Global Codeine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Narcotic Analgesic Major Manufacturers Table 6. Antitussive Major Manufacturers Table 7. Others Major Manufacturers Table 8. Codeine Industry Trends Table 9. Codeine Industry Drivers Table 10. Codeine Industry Opportunities and Challenges Table 11. Codeine Industry Restraints Table 12. Global Codeine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Codeine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Codeine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Codeine Revenue Market Share by Region (2021-2026) Table 16. Global Codeine Revenue Market Share by Region (2027-2032) Table 17. Global Codeine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 18. Global Codeine Sales by Region (2021-2026) & (M Units) Table 19. Global Codeine Sales by Region (2027-2032) & (M Units) Table 20. Global Codeine Sales Market Share by Region (2021-2026) Table 21. Global Codeine Sales Market Share by Region (2027-2032) Table 22. Global Codeine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Codeine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Codeine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Codeine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Codeine Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 27. Global Codeine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Codeine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Codeine Manufacturers, Product Type & Application Table 30. Global Codeine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Codeine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Codeine Revenue by Ingredient 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Codeine Revenue by Ingredient (2021-2026) & (US$ Million) Table 35. Global Codeine Revenue by Ingredient (2027-2032) & (US$ Million) Table 36. Global Codeine Revenue Market Share by Ingredient (2021-2026) Table 37. Global Codeine Revenue Market Share by Ingredient (2027-2032) Table 38. Global Codeine Sales by Ingredient 2021 VS 2025 VS 2032 (M Units) Table 39. Global Codeine Sales by Ingredient (2021-2026) & (M Units) Table 40. Global Codeine Sales by Ingredient (2027-2032) & (M Units) Table 41. Global Codeine Sales Market Share by Ingredient (2021-2026) Table 42. Global Codeine Sales Market Share by Ingredient (2027-2032) Table 43. Global Codeine Price by Ingredient (2021-2026) & (USD/Unit) Table 44. Global Codeine Price by Ingredient (2027-2032) & (USD/Unit) Table 45. Global Codeine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Codeine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Codeine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Codeine Revenue Market Share by Application (2021-2026) Table 49. Global Codeine Revenue Market Share by Application (2027-2032) Table 50. Global Codeine Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 51. Global Codeine Sales by Application (2021-2026) & (M Units) Table 52. Global Codeine Sales by Application (2027-2032) & (M Units) Table 53. Global Codeine Sales Market Share by Application (2021-2026) Table 54. Global Codeine Sales Market Share by Application (2027-2032) Table 55. Global Codeine Price by Application (2021-2026) & (USD/Unit) Table 56. Global Codeine Price by Application (2027-2032) & (USD/Unit) Table 57. Taiji Company Information Table 58. Taiji Business Overview Table 59. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 60. Taiji Codeine Product Portfolio Table 61. Taiji Recent Development Table 62. Mallinckrodt Company Information Table 63. Mallinckrodt Business Overview Table 64. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 65. Mallinckrodt Codeine Product Portfolio Table 66. Mallinckrodt Recent Development Table 67. TEVA Company Information Table 68. TEVA Business Overview Table 69. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. TEVA Codeine Product Portfolio Table 71. TEVA Recent Development Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Codeine Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Medreich Company Information Table 78. Medreich Business Overview Table 79. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Medreich Codeine Product Portfolio Table 81. Medreich Recent Development Table 82. Sanofi Aventis Company Information Table 83. Sanofi Aventis Business Overview Table 84. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Sanofi Aventis Codeine Product Portfolio Table 86. Sanofi Aventis Recent Development Table 87. Cipla Company Information Table 88. Cipla Business Overview Table 89. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Cipla Codeine Product Portfolio Table 91. Cipla Recent Development Table 92. Hikma Company Information Table 93. Hikma Business Overview Table 94. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Hikma Codeine Product Portfolio Table 96. Hikma Recent Development Table 97. Pharmaceutical Associates Company Information Table 98. Pharmaceutical Associates Business Overview Table 99. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Pharmaceutical Associates Codeine Product Portfolio Table 101. Pharmaceutical Associates Recent Development Table 102. Novartis Company Information Table 103. Novartis Business Overview Table 104. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Novartis Codeine Product Portfolio Table 106. Novartis Recent Development Table 107. Apotex Company Information Table 108. Apotex Business Overview Table 109. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Apotex Codeine Product Portfolio Table 111. Apotex Recent Development Table 112. Mylan Company Information Table 113. Mylan Business Overview Table 114. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Mylan Codeine Product Portfolio Table 116. Mylan Recent Development Table 117. Aristo Pharma GmbH Company Information Table 118. Aristo Pharma GmbH Business Overview Table 119. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Aristo Pharma GmbH Codeine Product Portfolio Table 121. Aristo Pharma GmbH Recent Development Table 122. Lannett Company Company Information Table 123. Lannett Company Business Overview Table 124. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Lannett Company Codeine Product Portfolio Table 126. Lannett Company Recent Development Table 127. Laboratoire Riva Company Information Table 128. Laboratoire Riva Business Overview Table 129. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Laboratoire Riva Codeine Product Portfolio Table 131. Laboratoire Riva Recent Development Table 132. North America Codeine Revenue by Ingredient (2021-2026) & (US$ Million) Table 133. North America Codeine Revenue by Ingredient (2027-2032) & (US$ Million) Table 134. North America Codeine Sales by Ingredient (2021-2026) & (M Units) Table 135. North America Codeine Sales by Ingredient (2027-2032) & (M Units) Table 136. North America Codeine Sales Price by Ingredient (2021-2026) & (USD/Unit) Table 137. North America Codeine Sales Price by Ingredient (2027-2032) & (USD/Unit) Table 138. North America Codeine Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Codeine Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Codeine Sales by Application (2021-2026) & (M Units) Table 141. North America Codeine Sales by Application (2027-2032) & (M Units) Table 142. North America Codeine Sales Price by Application (2021-2026) & (USD/Unit) Table 143. North America Codeine Sales Price by Application (2027-2032) & (USD/Unit) Table 144. North America Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Codeine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Codeine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Codeine Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 148. North America Codeine Sales by Country (2021-2026) & (M Units) Table 149. North America Codeine Sales by Country (2027-2032) & (M Units) Table 150. North America Codeine Sales Price by Country (2021-2026) & (USD/Unit) Table 151. North America Codeine Sales Price by Country (2027-2032) & (USD/Unit) Table 152. United States Codeine Revenue (2021-2032) & (US$ Million) Table 153. Canada Codeine Revenue (2021-2032) & (US$ Million) Table 154. Mexico Codeine Revenue (2021-2032) & (US$ Million) Table 155. Europe Codeine Revenue by Ingredient (2021-2026) & (US$ Million) Table 156. Europe Codeine Revenue by Ingredient (2027-2032) & (US$ Million) Table 157. Europe Codeine Sales by Ingredient (2021-2026) & (M Units) Table 158. Europe Codeine Sales by Ingredient (2027-2032) & (M Units) Table 159. Europe Codeine Sales Price by Ingredient (2021-2026) & (USD/Unit) Table 160. Europe Codeine Sales Price by Ingredient (2027-2032) & (USD/Unit) Table 161. Europe Codeine Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Codeine Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Codeine Sales by Application (2021-2026) & (M Units) Table 164. Europe Codeine Sales by Application (2027-2032) & (M Units) Table 165. Europe Codeine Sales Price by Application (2021-2026) & (USD/Unit) Table 166. Europe Codeine Sales Price by Application (2027-2032) & (USD/Unit) Table 167. Europe Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Codeine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Codeine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Codeine Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 171. Europe Codeine Sales by Country (2021-2026) & (M Units) Table 172. Europe Codeine Sales by Country (2027-2032) & (M Units) Table 173. Europe Codeine Sales Price by Country (2021-2026) & (USD/Unit) Table 174. Europe Codeine Sales Price by Country (2027-2032) & (USD/Unit) Table 175. Germany Codeine Revenue (2021-2032) & (US$ Million) Table 176. France Codeine Revenue (2021-2032) & (US$ Million) Table 177. U.K. Codeine Revenue (2021-2032) & (US$ Million) Table 178. Italy Codeine Revenue (2021-2032) & (US$ Million) Table 179. Russia Codeine Revenue (2021-2032) & (US$ Million) Table 180. Spain Codeine Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Codeine Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Codeine Revenue (2021-2032) & (US$ Million) Table 183. Sweden Codeine Revenue (2021-2032) & (US$ Million) Table 184. Poland Codeine Revenue (2021-2032) & (US$ Million) Table 185. China Codeine Revenue by Ingredient (2021-2026) & (US$ Million) Table 186. China Codeine Revenue by Ingredient (2027-2032) & (US$ Million) Table 187. China Codeine Sales by Ingredient (2021-2026) & (M Units) Table 188. China Codeine Sales by Ingredient (2027-2032) & (M Units) Table 189. China Codeine Sales Price by Ingredient (2021-2026) & (USD/Unit) Table 190. China Codeine Sales Price by Ingredient (2027-2032) & (USD/Unit) Table 191. China Codeine Revenue by Application (2021-2026) & (US$ Million) Table 192. China Codeine Revenue by Application (2027-2032) & (US$ Million) Table 193. China Codeine Sales by Application (2021-2026) & (M Units) Table 194. China Codeine Sales by Application (2027-2032) & (M Units) Table 195. China Codeine Sales Price by Application (2021-2026) & (USD/Unit) Table 196. China Codeine Sales Price by Application (2027-2032) & (USD/Unit) Table 197. Asia Codeine Revenue by Ingredient (2021-2026) & (US$ Million) Table 198. Asia Codeine Revenue by Ingredient (2027-2032) & (US$ Million) Table 199. Asia Codeine Sales by Ingredient (2021-2026) & (M Units) Table 200. Asia Codeine Sales by Ingredient (2027-2032) & (M Units) Table 201. Asia Codeine Sales Price by Ingredient (2021-2026) & (USD/Unit) Table 202. Asia Codeine Sales Price by Ingredient (2027-2032) & (USD/Unit) Table 203. Asia Codeine Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Codeine Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Codeine Sales by Application (2021-2026) & (M Units) Table 206. Asia Codeine Sales by Application (2027-2032) & (M Units) Table 207. Asia Codeine Sales Price by Application (2021-2026) & (USD/Unit) Table 208. Asia Codeine Sales Price by Application (2027-2032) & (USD/Unit) Table 209. Asia Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Codeine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Codeine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Codeine Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 213. Asia Codeine Sales by Country (2021-2026) & (M Units) Table 214. Asia Codeine Sales by Country (2027-2032) & (M Units) Table 215. Asia Codeine Sales Price by Country (2021-2026) & (USD/Unit) Table 216. Asia Codeine Sales Price by Country (2027-2032) & (USD/Unit) Table 217. Japan Codeine Revenue (2021-2032) & (US$ Million) Table 218. South Korea Codeine Revenue (2021-2032) & (US$ Million) Table 219. India Codeine Revenue (2021-2032) & (US$ Million) Table 220. Australia Codeine Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Codeine Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Codeine Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Codeine Revenue by Ingredient (2021-2026) & (US$ Million) Table 224. SAMEA Codeine Revenue by Ingredient (2027-2032) & (US$ Million) Table 225. SAMEA Codeine Sales by Ingredient (2021-2026) & (M Units) Table 226. SAMEA Codeine Sales by Ingredient (2027-2032) & (M Units) Table 227. SAMEA Codeine Sales Price by Ingredient (2021-2026) & (USD/Unit) Table 228. SAMEA Codeine Sales Price by Ingredient (2027-2032) & (USD/Unit) Table 229. SAMEA Codeine Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Codeine Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Codeine Sales by Application (2021-2026) & (M Units) Table 232. SAMEA Codeine Sales by Application (2027-2032) & (M Units) Table 233. SAMEA Codeine Sales Price by Application (2021-2026) & (USD/Unit) Table 234. SAMEA Codeine Sales Price by Application (2027-2032) & (USD/Unit) Table 235. SAMEA Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Codeine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Codeine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Codeine Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 239. SAMEA Codeine Sales by Country (2021-2026) & (M Units) Table 240. SAMEA Codeine Sales by Country (2027-2032) & (M Units) Table 241. SAMEA Codeine Sales Price by Country (2021-2026) & (USD/Unit) Table 242. SAMEA Codeine Sales Price by Country (2027-2032) & (USD/Unit) Table 243. Brazil Codeine Revenue (2021-2032) & (US$ Million) Table 244. Argentina Codeine Revenue (2021-2032) & (US$ Million) Table 245. Chile Codeine Revenue (2021-2032) & (US$ Million) Table 246. Colombia Codeine Revenue (2021-2032) & (US$ Million) Table 247. Peru Codeine Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Codeine Revenue (2021-2032) & (US$ Million) Table 249. Israel Codeine Revenue (2021-2032) & (US$ Million) Table 250. UAE Codeine Revenue (2021-2032) & (US$ Million) Table 251. Turkey Codeine Revenue (2021-2032) & (US$ Million) Table 252. Iran Codeine Revenue (2021-2032) & (US$ Million) Table 253. Egypt Codeine Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Codeine Distributors List Table 257. Codeine Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Codeine Image Figure 2. Global Codeine Market Size Growth Rate by Ingredient (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-ingredient Codeine Image Figure 5. Multi-ingredient Medications Image Figure 6. Global Codeine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Codeine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Narcotic Analgesic Image Figure 9. Antitussive Image Figure 10. Others Image Figure 11. Global Codeine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Codeine Revenue (2021-2032) & (US$ Million) Figure 13. Global Codeine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Codeine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Codeine Revenue Market Share by Region (2021-2032) Figure 16. Global Codeine Sales (2021-2032) & (M Units) Figure 17. Global Codeine Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 18. Global Codeine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Codeine Sales YoY (2021-2032) & (M Units) Figure 20. Europe Codeine Sales YoY (2021-2032) & (M Units) Figure 21. China Codeine Sales YoY (2021-2032) & (M Units) Figure 22. Asia (Excluding China) Codeine Sales YoY (2021-2032) & (M Units) Figure 23. South America, Middle East and Africa Codeine Sales YoY (2021-2032) & (M Units) Figure 24. Global Codeine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Codeine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Codeine Revenue by Ingredient (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Codeine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Codeine Revenue Market Share by Ingredient (2021-2032) Figure 30. Global Codeine Sales by Ingredient (2021 VS 2025 VS 2032) & (M Units) Figure 31. Global Codeine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Codeine Sales Market Share by Ingredient (2021-2032) Figure 33. Global Codeine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Codeine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Codeine Revenue Market Share by Application (2021-2032) Figure 36. Global Codeine Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 37. Global Codeine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Codeine Sales Market Share by Application (2021-2032) Figure 39. North America Codeine Revenue Share by Ingredient (2021-2032) Figure 40. North America Codeine Sales Share by Ingredient (2021-2032) Figure 41. North America Codeine Revenue Share by Application (2021-2032) Figure 42. North America Codeine Sales Share by Application (2021-2032) Figure 43. North America Codeine Revenue Share by Country (2021-2032) Figure 44. North America Codeine Sales Share by Country (2021-2032) Figure 45. Europe Codeine Revenue Share by Ingredient (2021-2032) Figure 46. Europe Codeine Sales Share by Ingredient (2021-2032) Figure 47. Europe Codeine Revenue Share by Application (2021-2032) Figure 48. Europe Codeine Sales Share by Application (2021-2032) Figure 49. Europe Codeine Revenue Share by Country (2021-2032) Figure 50. Europe Codeine Sales Share by Country (2021-2032) Figure 51. China Codeine Revenue Share by Ingredient (2021-2032) Figure 52. China Codeine Sales Share by Ingredient (2021-2032) Figure 53. China Codeine Revenue Share by Application (2021-2032) Figure 54. China Codeine Sales Share by Application (2021-2032) Figure 55. Asia Codeine Revenue Share by Ingredient (2021-2032) Figure 56. Asia Codeine Sales Share by Ingredient (2021-2032) Figure 57. Asia Codeine Revenue Share by Application (2021-2032) Figure 58. Asia Codeine Sales Share by Application (2021-2032) Figure 59. Asia Codeine Revenue Share by Country (2021-2032) Figure 60. Asia Codeine Sales Share by Country (2021-2032) Figure 61. SAMEA Codeine Revenue Share by Ingredient (2021-2032) Figure 62. SAMEA Codeine Sales Share by Ingredient (2021-2032) Figure 63. SAMEA Codeine Revenue Share by Application (2021-2032) Figure 64. SAMEA Codeine Sales Share by Application (2021-2032) Figure 65. SAMEA Codeine Revenue Share by Country (2021-2032) Figure 66. SAMEA Codeine Sales Share by Country (2021-2032) Figure 67. Codeine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Codeine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • Taiji
  • Mallinckrodt
  • TEVA
  • Johnson & Johnson
  • Medreich
  • Sanofi Aventis
  • Cipla
  • Hikma
  • Pharmaceutical Associates
  • Novartis
  • Apotex
  • Mylan
  • Aristo Pharma GmbH
  • Lannett Company
  • Laboratoire Riva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Codeine Market by Ingredient
  3. 1.2.1 Global Codeine Market Size by Ingredient, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-ingredient Codeine
  5. 1.2.3 Multi-ingredient Medications
  6. 1.3 Codeine Market by Application
  7. 1.3.1 Global Codeine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Narcotic Analgesic
  9. 1.3.3 Antitussive
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Codeine Market Dynamics
  1. 2.1 Codeine Industry Trends
  2. 2.2 Codeine Industry Drivers
  3. 2.3 Codeine Industry Opportunities and Challenges
  4. 2.4 Codeine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Codeine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Codeine Revenue by Region
  3. 3.2.1 Global Codeine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Codeine Revenue by Region (2021-2026)
  5. 3.2.3 Global Codeine Revenue by Region (2027-2032)
  6. 3.2.4 Global Codeine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Codeine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Codeine Sales by Region
  9. 3.4.1 Global Codeine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Codeine Sales by Region (2021-2026)
  11. 3.4.3 Global Codeine Sales by Region (2027-2032)
  12. 3.4.4 Global Codeine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Codeine Revenue by Manufacturers
  2. 4.1.1 Global Codeine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Codeine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Codeine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Codeine Sales by Manufacturers
  6. 4.2.1 Global Codeine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Codeine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Codeine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Codeine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Codeine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Codeine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Codeine Manufacturers, Product Type & Application
  13. 4.7 Global Codeine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Codeine Market CR5 and HHI
  16. 4.8.2 2025 Codeine Tier 1, Tier 2, and Tier 3
5 Codeine Market by Type
  1. 5.1 Global Codeine Revenue by Type
  2. 5.1.1 Global Codeine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Codeine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Codeine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Codeine Sales by Type
  6. 5.2.1 Global Codeine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Codeine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Codeine Price by Type
6 Codeine Market by Application
  1. 6.1 Global Codeine Revenue by Application
  2. 6.1.1 Global Codeine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Codeine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Codeine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Codeine Sales by Application
  6. 6.2.1 Global Codeine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Codeine Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Codeine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Codeine Price by Application
7 Company Profiles
  1. 7.1 Taiji
  2. 7.1.1 Taiji Company Information
  3. 7.1.2 Taiji Business Overview
  4. 7.1.3 Taiji Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Taiji Codeine Product Portfolio
  6. 7.1.5 Taiji Recent Developments
  7. 7.2 Mallinckrodt
  8. 7.2.1 Mallinckrodt Company Information
  9. 7.2.2 Mallinckrodt Business Overview
  10. 7.2.3 Mallinckrodt Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mallinckrodt Codeine Product Portfolio
  12. 7.2.5 Mallinckrodt Recent Developments
  13. 7.3 TEVA
  14. 7.3.1 TEVA Company Information
  15. 7.3.2 TEVA Business Overview
  16. 7.3.3 TEVA Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TEVA Codeine Product Portfolio
  18. 7.3.5 TEVA Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Codeine Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Medreich
  26. 7.5.1 Medreich Company Information
  27. 7.5.2 Medreich Business Overview
  28. 7.5.3 Medreich Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Medreich Codeine Product Portfolio
  30. 7.5.5 Medreich Recent Developments
  31. 7.6 Sanofi Aventis
  32. 7.6.1 Sanofi Aventis Company Information
  33. 7.6.2 Sanofi Aventis Business Overview
  34. 7.6.3 Sanofi Aventis Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Aventis Codeine Product Portfolio
  36. 7.6.5 Sanofi Aventis Recent Developments
  37. 7.7 Cipla
  38. 7.7.1 Cipla Company Information
  39. 7.7.2 Cipla Business Overview
  40. 7.7.3 Cipla Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cipla Codeine Product Portfolio
  42. 7.7.5 Cipla Recent Developments
  43. 7.8 Hikma
  44. 7.8.1 Hikma Company Information
  45. 7.8.2 Hikma Business Overview
  46. 7.8.3 Hikma Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hikma Codeine Product Portfolio
  48. 7.8.5 Hikma Recent Developments
  49. 7.9 Pharmaceutical Associates
  50. 7.9.1 Pharmaceutical Associates Company Information
  51. 7.9.2 Pharmaceutical Associates Business Overview
  52. 7.9.3 Pharmaceutical Associates Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pharmaceutical Associates Codeine Product Portfolio
  54. 7.9.5 Pharmaceutical Associates Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Codeine Product Portfolio
  60. 7.10.5 Novartis Recent Developments
  61. 7.11 Apotex
  62. 7.11.1 Apotex Company Information
  63. 7.11.2 Apotex Business Overview
  64. 7.11.3 Apotex Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Apotex Codeine Product Portfolio
  66. 7.11.5 Apotex Recent Developments
  67. 7.12 Mylan
  68. 7.12.1 Mylan Company Information
  69. 7.12.2 Mylan Business Overview
  70. 7.12.3 Mylan Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Mylan Codeine Product Portfolio
  72. 7.12.5 Mylan Recent Developments
  73. 7.13 Aristo Pharma GmbH
  74. 7.13.1 Aristo Pharma GmbH Company Information
  75. 7.13.2 Aristo Pharma GmbH Business Overview
  76. 7.13.3 Aristo Pharma GmbH Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Aristo Pharma GmbH Codeine Product Portfolio
  78. 7.13.5 Aristo Pharma GmbH Recent Developments
  79. 7.14 Lannett Company
  80. 7.14.1 Lannett Company Company Information
  81. 7.14.2 Lannett Company Business Overview
  82. 7.14.3 Lannett Company Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Lannett Company Codeine Product Portfolio
  84. 7.14.5 Lannett Company Recent Developments
  85. 7.15 Laboratoire Riva
  86. 7.15.1 Laboratoire Riva Company Information
  87. 7.15.2 Laboratoire Riva Business Overview
  88. 7.15.3 Laboratoire Riva Codeine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Laboratoire Riva Codeine Product Portfolio
  90. 7.15.5 Laboratoire Riva Recent Developments
8 North America
  1. 8.1 North America Codeine Market Size by Ingredient
  2. 8.1.1 North America Codeine Revenue by Ingredient (2021-2032)
  3. 8.1.2 North America Codeine Sales by Ingredient (2021-2032)
  4. 8.1.3 North America Codeine Price by Ingredient (2021-2032)
  5. 8.2 North America Codeine Market Size by Application
  6. 8.2.1 North America Codeine Revenue by Application (2021-2032)
  7. 8.2.2 North America Codeine Sales by Application (2021-2032)
  8. 8.2.3 North America Codeine Price by Application (2021-2032)
  9. 8.3 North America Codeine Market Size by Country
  10. 8.3.1 North America Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Codeine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Codeine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Codeine Market Size by Ingredient
  2. 9.1.1 Europe Codeine Revenue by Ingredient (2021-2032)
  3. 9.1.2 Europe Codeine Sales by Ingredient (2021-2032)
  4. 9.1.3 Europe Codeine Price by Ingredient (2021-2032)
  5. 9.2 Europe Codeine Market Size by Application
  6. 9.2.1 Europe Codeine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Codeine Sales by Application (2021-2032)
  8. 9.2.3 Europe Codeine Price by Application (2021-2032)
  9. 9.3 Europe Codeine Market Size by Country
  10. 9.3.1 Europe Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Codeine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Codeine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Codeine Market Size by Ingredient
  2. 10.1.1 China Codeine Revenue by Ingredient (2021-2032)
  3. 10.1.2 China Codeine Sales by Ingredient (2021-2032)
  4. 10.1.3 China Codeine Price by Ingredient (2021-2032)
  5. 10.2 China Codeine Market Size by Application
  6. 10.2.1 China Codeine Revenue by Application (2021-2032)
  7. 10.2.2 China Codeine Sales by Application (2021-2032)
  8. 10.2.3 China Codeine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Codeine Market Size by Ingredient
  2. 11.1.1 Asia Codeine Revenue by Ingredient (2021-2032)
  3. 11.1.2 Asia Codeine Sales by Ingredient (2021-2032)
  4. 11.1.3 Asia Codeine Price by Ingredient (2021-2032)
  5. 11.2 Asia Codeine Market Size by Application
  6. 11.2.1 Asia Codeine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Codeine Sales by Application (2021-2032)
  8. 11.2.3 Asia Codeine Price by Application (2021-2032)
  9. 11.3 Asia Codeine Market Size by Country
  10. 11.3.1 Asia Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Codeine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Codeine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Codeine Market Size by Ingredient
  2. 12.1.1 SAMEA Codeine Revenue by Ingredient (2021-2032)
  3. 12.1.2 SAMEA Codeine Sales by Ingredient (2021-2032)
  4. 12.1.3 SAMEA Codeine Price by Ingredient (2021-2032)
  5. 12.2 SAMEA Codeine Market Size by Application
  6. 12.2.1 SAMEA Codeine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Codeine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Codeine Price by Application (2021-2032)
  9. 12.3 SAMEA Codeine Market Size by Country
  10. 12.3.1 SAMEA Codeine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Codeine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Codeine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Codeine Value Chain Analysis
  2. 13.1.1 Codeine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Codeine Production Mode & Process
  6. 13.2 Codeine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Codeine Distributors
  9. 13.2.3 Codeine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst